Abstract
Objective
To investigate whether obesity and hormone therapy (HT) are associated with ovarian cancer risk among women in the California Teachers Study cohort.
Methods
Of 56,091 women age ≥45 years, 277 developed epithelial ovarian cancer between 1995 and 2007. Multivariate Cox regression was performed.
Results
Among women who never used HT, greater adult weight gain, waist circumference and waist-to-height ratio, but not adult BMI, increased risk of ovarian cancer. Compared to women who never used HT and had a stable adult weight, risk of ovarian cancer was increased in women who gained ≥40 lb (relative risk (RR) 1.8, 95% confidence interval (CI): 1.0–3.0) or used HT for >5 years (RR 2.3 95% CI: 1.3–4.1). Having both exposures (RR 1.9, 95% CI: 0.99–3.5), however, did not increase risk more than having either alone. Results were similar for waist circumference and weight-to-height ratio; however, differences across HT groups were not statistically significant.
Conclusions
This study suggests that abdominal adiposity and weight gain, but not overall obesity, increase ovarian cancer risk and that there may be a threshold level beyond which additional hormones, whether exogenous or endogenous, do not result in additional elevation in risk. However, large pooled analyses are needed to confirm these findings.
Similar content being viewed by others
References
World Cancer Research Fund and the American Institute for Cancer Research (2007) Food, Nutrition and the Prevention of Cancer: A Global Perspective
Olsen CM, Green AC, Whiteman DC, Sadeghi S, Kolahdooz F, Webb PM (2007) Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer 43:690–709
Purdie DM, Bain CJ, Webb PM, Whiteman DC, Pirozzo S, Green AC (2001) Body size and ovarian cancer: case-control study and systematic review (Australia). Cancer Causes Control 12:855–863
Schouten LJ, Rivera C, Hunter DJ et al (2008) Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 17:902–912
Folsom AR, Anderson JP, Ross JA (2004) Estrogen replacement therapy and ovarian cancer. Epidemiology 15:100–104
Lacey JV Jr, Mink PJ, Lubin JH et al (2002) Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 288:334–341
Lacey JV Jr, Brinton LA, Leitzmann MF et al (2006) Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort. J Natl Cancer Inst 98:1397–1405
Riman T, Dickman PW, Nilsson S et al (2002) Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. J Natl Cancer Inst 94:497–504
Vo C, Carney ME (2007) Ovarian cancer hormonal and environmental risk effect. Obstet Gynecol Clin North Am 34:687–700, viii
Key TJ, Allen NE, Verkasalo PK, Banks E (2001) Energy balance and cancer: the role of sex hormones. Proc Nutr Soc 60:81–89
Kaye SA, Folsom AR, Soler JT, Prineas RJ, Potter JD (1991) Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int J Epidemiol 20:151–156
Potischman N, Swanson CA, Siiteri P, Hoover RN (1996) Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst 88:756–758
Bernstein L (2006) The risk of breast, endometrial and ovarian cancer in users of hormonal preparations. Basic Clin Pharmacol Toxicol 98:288–296
Bernstein L, Allen M, Anton-Culver H et al (2002) High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control 13:625–635
Kwong SL, Perkins CI, Morris CR et al (2001) Cancer in California: 1988–1999. California Department of Health Services, Cancer Surveillance Section, December, Sacramento, CA
Chen VW, Ruiz B, Killeen JL, Cote TR, Wu XC, Correa CN (2003) Pathology and classification of ovarian tumors. Cancer 97:2631–2642
Molarius A, Seidell JC (1998) Selection of anthropometric indicators for classification of abdominal fatness–a critical review. Int J Obes Relat Metab Disord 22:719–727
Chang ET, Canchola AJ, Lee VS et al (2007) Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohort. Cancer Causes Control 18:91–103
Chang ET, Lee VS, Canchola AJ et al (2007) Diet and risk of ovarian cancer in the California Teachers Study cohort. Am J Epidemiol 165:802–813
Hamilton W, Menon W (2010) Easily missed? Ovarian cancer. Brit Med J 340:96–97
Lataifeh I, Marsden DE, Robertson G, Gebski V, Hacker NF (2005) Presenting symptoms of epithelial ovarian cancer. Aust N Z J Obstet Gynaecol 45:211–214
Roett MA, Evans P (2009) Ovarian cancer: an overview. Am Fam Physician 80:609–616
Webb PM, Purdie DM, Grover S, Jordan S, Dick ML, Green AC (2004) Symptoms and diagnosis of borderline, early and advanced epithelial ovarian cancer. Gynecol Oncol 92:232–239
Kurian AW, Balise RR, McGuire V, Whittemore AS (2005) Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol 96:520–530
Anderson JP, Ross JA, Folsom AR (2004) Anthropometric variables, physical activity, and incidence of ovarian cancer: the Iowa Women’s Health Study. Cancer 100:1515–1521
Baer HJ, Hankinson SE, Tworoger SS (2008) Body size in early life and risk of epithelial ovarian cancer: results from the Nurses’ Health Studies. Br J Cancer 99:1916–1922
Beehler GP, Sekhon M, Baker JA et al (2006) Risk of ovarian cancer associated with BMI varies by menopausal status. J Nutr 136:2881–2886
Fairfield KM, Willett WC, Rosner BA, Manson JE, Speizer FE, Hankinson SE (2002) Obesity, weight gain, and ovarian cancer. Obstet Gynecol 100:288–296
Kuper H, Cramer DW, Titus-Ernstoff L (2002) Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status? Cancer Causes Control 13:455–463
Peterson NB, Trentham-Dietz A, Newcomb PA et al (2006) Relation of anthropometric measurements to ovarian cancer risk in a population-based case-control study (United States). Cancer Causes Control 17:459–467
Schouten LJ, Goldbohm RA, van den Brandt PA (2003) Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer. Am J Epidemiol 157:424–433
Lahmann PH, Cust AE, Friedenreich CM et al (2009) Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 126:2404–2415
Kotsopoulos J, Baer HJ, Tworoger SS (2009) Anthropometric Measures and Risk of Epithelial Ovarian Cancer: results from the nurses’ health study. Obesity 18:1625–1631
Leitzmann MF, Koebnick C, Danforth KN et al (2009) Body mass index and risk of ovarian cancer. Cancer 115:812–822
Acknowledgments
This research was supported by grant R01 CA77398 from the National Cancer Institute and contract 97-10500 from the California Breast Cancer Research Fund. The funding sources did not contribute to the design or conduct of the study, nor to the writing or submission of this manuscript. The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Sect. 103885; the National Cancer Institute’s Surveillance, Epidemiology and End Results Program under contract N01-PC-35136 awarded to the Cancer Prevention Institute of California (formerly the Northern California Cancer Center), contract N01-PC-35139 awarded to the University of Southern California, and contract N02-PC-15105 awarded to the Public Health Institute; and the Centers for Disease Control and Prevention’s National Program of Cancer Registries, under agreement #U55/CCR921930-02 awarded to the Public Health Institute. The ideas and opinions expressed herein are those of the authors and endorsement by the State of California, Department of Public Health, the National Cancer Institute, and the Centers for Disease Control and Prevention or their contractors and subcontractors is not intended nor should be inferred. The authors would like to thank the CTS Steering Committee who are responsible for the formation and maintenance of the cohort within which this study was conducted but who did not directly contribute to the current paper: Hoda Anton-Culver, Christina A. Clarke, James V. Lacey Jr., Huiyan Ma, David O. Nelson, Susan L. Neuhausen, Rich Pinder, Frederick Schumacher, Daniel O. Stram, Sophia S. Wang, Dee W. West, and Argyrios Ziogas.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Canchola, A.J., Chang, E.T., Bernstein, L. et al. Body size and the risk of ovarian cancer by hormone therapy use in the California Teachers Study cohort. Cancer Causes Control 21, 2241–2248 (2010). https://doi.org/10.1007/s10552-010-9647-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-010-9647-x